Search Within

Gregory J Riely

Formats
  1. Journal Article (291)
  2. Meeting Abstract (264)
  3. Book Section (16)
  4. Guidelines (14)
  5. Conference Paper (4)
  6. Review (4)
  7. Editorial (3)
  8. Book Whole (1)
  9. Correspondence (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (599)
  2. Solid Tumor Oncology Division (599)
  3. Thoracic Oncology (599)
  4. Department of Pathology and Laboratory Medicine (260)
  5. GSK Faculty (244)
  6. Human Oncology and Pathogenesis Program (219)

More Groups

People
  1. Mark Kris (220)
  2. Marc Ladanyi (187)
  3. Helena Yu (107)
  4. Maria Arcila (85)
  5. Vincent Miller (79)
  6. Charles Rudin (75)

More People

Years
  1. 2025 (3)
  2. 2024 (25)
  3. 2023 (45)
  4. 2022 (39)
  5. 2021 (41)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Journal of Thoracic Oncology (112)
  3. Clinical Cancer Research (46)
  4. Annals of Oncology (31)
  5. Journal of the National Comprehensive Cancer Network (25)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (173)
  2. Elsevier Inc. (136)
  3. American Association for Cancer Research (77)
  4. Oxford University Press (38)
  5. Harborside Press (25)
  6. Elsevier Science, Inc. (23)

More Publishers

Results (599)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A. J.; Chan, J. M.; Rizvi, H.; Rekhtman, N.; Daneshbod, Y.; Kubota, D.; Chang, J. C.; Arcila, M. E.; Ladanyi, M.; Somwar, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Real-world utilization of EGFR TKI therapies and treatment outcomes in patients with advanced EGFR-sensitizing mutation-positive NSCLC
    Meeting Abstract

    Riely, G. J.; Lovly, C. M.; Messina, C. G. M.; Bienert, S.; Alexander, K.; Pao, W.; Baxi, S.; Doebele, R. C.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of platinum-pemetrexed combination chemotherapy in ALK+ non-small cell lung cancer refractory to second-generation ALK TKIs
    Meeting Abstract

    Lin, J. J.; Schoenfeld, A. J.; Zhu, V. W.; Yeap, B. Y.; Chin, E.; Rooney, M.; Plodkowski, A. J.; Digumarthy, S.; Dagogo-Jack, I.; Gainor, J. F.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Antitumor activity of TAK-788 in NSCLC with EGFR exon 20 insertions
    Meeting Abstract

    Janne, P. A.; Neal, J. W.; Camidge, D. R.; Spira, A. I.; Piotrowska, Z.; Horn, L.; Costa, D. B.; Tsao, A. S.; Patel, J. D.; Gadgeel, S. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Antitumor activity of TAK-788 in NSCLC with EGFR exon 20 insertions
    Meeting Abstract

    Janne, P. A.; Neal, J. W.; Camidge, D. R.; Spira, A.; Piotrowska, Z.; Horn, L.; Costa, D. B.; Tsao, A.; Patel, J.; Gadgeel, S.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): Updated results, including overall survival, from PROFILE 1001
    Journal Article

    Shaw, A. T.; Riely, G. J.; Bang, Y. J.; Kim, D. W.; Camidge, D. R.; Solomon, B. J.; Varella-Garcia, M.; Iafrate, A. J.; Shapiro, G. I.; Usari, T.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
    Journal Article

    Schoenfeld, A. J.; Arbour, K. C.; Rizvi, H.; Iqbal, A. N.; Gadgeel, S. M.; Girshman, J.; Kris, M. G.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
    Journal Article

    Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Systemic therapy for locally advanced and metastatic non-small cell lung cancer: A review
    Review

    Arbour, K. C.; Riely, G. J.
    JAMA - Journal of the American Medical Association (2019)

    Fulltext@MSK | Save
  • Crizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): Overall survival (OS) and updated safety from PROFILE 1001
    Meeting Abstract

    Shaw, A.; Riely, G. J.; Bang, Y. J.; Kim, D. W.; Camidge, D. R.; Shapiro, G. I.; Usari, T.; Wang, S. C.; Wilner, K.; Clark, J. W.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save